These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 77920)

  • 21. Multiple sclerosis: basic immunology.
    Hauser SL
    J Spinal Cord Med; 1998 Apr; 21(2):106-8. PubMed ID: 9697083
    [No Abstract]   [Full Text] [Related]  

  • 22. MS and EAE.
    Lancet; 1979 Nov; 2(8150):1001-2. PubMed ID: 91724
    [No Abstract]   [Full Text] [Related]  

  • 23. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encephalitogenic activity of the N-terminal part of bovine myelin basic protein in rabbits.
    Bergstrand H
    Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):442-6. PubMed ID: 63226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
    Béraud-Juven E
    Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimyelin basic protein antibodies and cellular hypersensitivity in multiple sclerosis.
    Sheremata W; Wood DD; Moscarello MA
    Trans Am Neurol Assoc; 1976; 101():291-4. PubMed ID: 1028264
    [No Abstract]   [Full Text] [Related]  

  • 28. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls.
    Sun JB; Olsson T; Wang WZ; Xiao BG; Kostulas V; Fredrikson S; Ekre HP; Link H
    Eur J Immunol; 1991 Jun; 21(6):1461-8. PubMed ID: 1710567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catalytic autoantibodies in multiple sclerosis: pathogenetic and clinical aspects.
    Misikov VK; Kimova MV; Durova OM; Gabibov AG; Suchkov SV; Vorobev II; Ponomarenko NA
    Bull Exp Biol Med; 2005 Jan; 139(1):85-8. PubMed ID: 16142285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibodies against encephalitogenic protein and myelin glycoprotein in the cerebrospinal fluid of patients with multiple sclerosis. Effect of encorton treatment on the autoantibody and immune complex levels].
    Waigt A; Górny MK
    Folia Med Cracov; 1984; 25(3-4):307-18. PubMed ID: 6085729
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 32. The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis.
    Bartlett PF; Mackay IR
    J Clin Lab Immunol; 1983 May; 11(1):1-7. PubMed ID: 6348293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.
    Kuerten S; Schickel A; Kerkloh C; Recks MS; Addicks K; Ruddle NH; Lehmann PV
    Acta Neuropathol; 2012 Dec; 124(6):861-73. PubMed ID: 22842876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD8⁺ T cell help is required for efficient induction of EAE in Lewis rats.
    Camara M; Beyersdorf N; Fischer HJ; Herold MJ; Ip CW; van den Brandt J; Toyka KV; Taurog JD; Hünig T; Herrmann T; Reichardt HM; Weishaupt A; Kerkau T
    J Neuroimmunol; 2013 Jul; 260(1-2):17-27. PubMed ID: 23664330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis.
    Batoulis H; Wunsch M; Birkenheier J; Rottlaender A; Gorboulev V; Kuerten S
    Clin Immunol; 2015 May; 158(1):47-58. PubMed ID: 25796192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmunity to collagen II and myelin basic protein: comparative studies in humans and rodents.
    Klareskog L; Olsson T
    Immunol Rev; 1990 Dec; 118():285-310. PubMed ID: 1706680
    [No Abstract]   [Full Text] [Related]  

  • 37. Substrate specificity of catalytic autoantibodies in neurodegenerative processes.
    Belogurov AA; Kurkova IN; Misikov VK; Suchkov SV; Telegin GB; Alekhine AI; Goncharov NG; Knorre VD; Gabibov AG; Ponomarenko NA
    Dokl Biochem Biophys; 2007; 413():61-4. PubMed ID: 17546954
    [No Abstract]   [Full Text] [Related]  

  • 38. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunochemistry and biochemistry of myelin.
    Davison AN; Cuzner ML
    Br Med Bull; 1977 Jan; 33(1):60-6. PubMed ID: 64271
    [No Abstract]   [Full Text] [Related]  

  • 40. Myelin basic protein and its antibodies in the cerebrospinal fluid in experimental allergic encephalomyelitis, multiple sclerosis and other diseases.
    Alvord EC; Hruby S; Shaw CM; Slimp J
    Prog Clin Biol Res; 1984; 146():359-63. PubMed ID: 6201907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.